1. Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. (15th February 2018) Authors: Stoneham, Sara J.; Hale, Juliet P.; Rodriguez‐Galindo, Carlos; Dang, Ha; Olson, Thomas; Murray, Matthew; Amatruda, James F.; Thornton, Claire; Arul, G. Suren; Billmire, Deborah; Krailo, Mark; Stark, Dan; Covens, Al; Hurteau, Jean; Stenning, Sally; Nicholson, James C.; Gershenson, David; Frazier, ... Journal: Oncologist Issue: Volume 23:Number 2(2018) Page Start: 272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. (4th June 2014) Authors: Stoneham, Sara J.; Hale, Juliet P.; Rodriguez-Galindo, Carlos; Dang, Ha; Olson, Thomas; Murray, Matthew; Amatruda, James F.; Thornton, Claire; Arul, G. Suren; Billmire, Deborah; Krailo, Mark; Stark, Dan; Covens, Al; Hurteau, Jean; Stenning, Sally; Nicholson, James C.; Gershenson, David; Frazier, ... Journal: Oncologist Issue: Volume 19:Number 7(2014) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors. (4th June 2014) Authors: Stoneham, Sara J.; Hale, Juliet P.; Rodriguez‐Galindo, Carlos; Dang, Ha; Olson, Thomas; Murray, Matthew; Amatruda, James F.; Thornton, Claire; Arul, G. Suren; Billmire, Deborah; Krailo, Mark; Stark, Dan; Covens, Al; Hurteau, Jean; Stenning, Sally; Nicholson, James C.; Gershenson, David; Frazier, ... Journal: Oncologist Issue: Volume 19:Number 7(2014) Page Start: 689 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial. Issue 9 (September 2017) Authors: Alderson, Derek; Cunningham, David; Nankivell, Matthew; Blazeby, Jane M; Griffin, S Michael; Crellin, Adrian; Grabsch, Heike I; Langer, Rupert; Pritchard, Susan; Okines, Alicia; Krysztopik, Richard; Coxon, Fareeda; Thompson, Joyce; Falk, Stephen; Robb, Clare; Stenning, Sally; Langley, Ruth E Journal: Lancet oncology Issue: Volume 18:Issue 9(2017:Sep.) Page Start: 1249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. Issue 10214 (7th December 2019) Authors: Clamp, Andrew R; James, Elizabeth C; McNeish, Iain A; Dean, Andrew; Kim, Jae-Weon; O'Donnell, Dearbhaile M; Hook, Jane; Coyle, Christopher; Blagden, Sarah; Brenton, James D; Naik, Raj; Perren, Tim; Sundar, Sudha; Cook, Adrian D; Gopalakrishnan, Gosala S; Gabra, Hani; Lord, Rosemary; Dark, Graham;... Journal: Lancet Issue: Volume 394:Issue 10214(2019) Page Start: 2084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗